| 1 |
35353151 | Topical Administration of 0.3% Tofacitinib Suppresses M1 Macrophage Polarization and Allograft Corneal Rejection by Blocking STAT1 Activation in the Rat Cornea. | 2022 Mar 2 |
1 |
| 2 |
34504562 | Tofacitinib protects intestinal epithelial cells against oxygen-glucose deprivation/reoxygenation injury by inhibiting the JAK/STAT3 signaling pathway. | 2021 Oct |
1 |
| 3 |
32615452 | Tofacitinib suppresses mast cell degranulation and attenuates experimental allergic conjunctivitis. | 2020 Sep |
1 |
| 4 |
31730866 | Inhibition of JAK-STAT and NF-κB signalling systems could be a novel therapeutic target against insulin resistance and type 2 diabetes. | 2019 Dec 15 |
2 |
| 5 |
23486212 | Effects of the Janus kinase inhibitor CP-690550 (tofacitinib) in a rat model of oxazolone-induced chronic dermatitis. | 2013 |
1 |